Cargando…
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception: a Cochrane systematic review
BACKGROUND: The coronavirus disease COVID-19 is associated with an increased risk of thrombotic events. Individuals with COVID-19 using hormonal contraception could be at additional risk for thromboembolism, but evidence is sparse. METHODS: We conducted a systematic review on the risk of thromboembo...
Autores principales: | Hansen, Katie, Cohen, Megan A, Ramanadhan, Shaalini, Paynter, Robin, Edelman, Alison, Henderson, Jillian T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359512/ https://www.ncbi.nlm.nih.gov/pubmed/36882324 http://dx.doi.org/10.1136/bmjsrh-2023-201792 |
Ejemplares similares
-
Association of Pharmacist Prescription With Dispensed Duration of Hormonal Contraception
por: Rodriguez, Maria I., et al.
Publicado: (2020) -
Systemic hormonal contraception and risk of venous thromboembolism
por: Heikinheimo, Oskari, et al.
Publicado: (2022) -
Use of Fluoxetine to Reduce Weight in Adults with Overweight or Obesity: Abridged Republication of the Cochrane Systematic Review
por: Serralde-Zuñiga, Aurora E., et al.
Publicado: (2022) -
First venous thromboembolism and hormonal contraceptives in young French women
por: Hugon-Rodin, Justine, et al.
Publicado: (2017) -
Antenatal, Intrapartum and Postpartum Interventions for Preventing Postpartum Urinary and Faecal Incontinence: An Umbrella Overview of Cochrane Systematic Reviews
por: Sananès, Juliette, et al.
Publicado: (2023)